Dissociation of tumor promoter-stimulated ornithine decarboxylase activity and DNA synthesis in mouse epidermis in vivo and in vitro by fluocinolone acetonide, a tumor-promotion inhibitor.
12-O-Tetradecanoyl phorbol-13-acetate (TPA), a tumor promoter, stimulates DNA synthesis in mouse epidermal cells in vivo and in vitro. This response appears to be mediated through polyamine metabolism because ornithine decarboxylase (L-ornithine carboxy-lyase, EC 4.1.1.17)activity is markedly increased shortly after promoter exposure and this induction varies in magnitude according to dose and promoter potency of a series of phorbol esters. In vitro, exogenous putrescine (0.01-10 mM) results in a dose-related increase and prolongation of promoter-stimulated DNA DNA synthesis, a phenomenon noted in other systems of polyamine-mediated growth stimulation. The anti-inflammatory steroid fluocinolone acetonide (FA), an inhibitor of tumor promotion, prevents TPA stimulation of epidermal proliferation in vivo and in vitro. In vitro, FA most effectively prevents stimulation of DNA synthesis when applied is not required. Paradoxially, FA potentiates the increase in ornithine decarboxylase activity after TPA administeration both in vivo and in vitro. Furthermore, the inhibition of TPA-stimulated DNA synthesis by FA in vitro can be reversed by exogenous putrescine. These results suggestthat FA exerts its antipromotion effect by reducing the sensitivity of the cell to polyamines or by reducing intracellular polyamine levels.
D000818:Animals; D002262:Carboxy-Lyases / Q000378:metabolism*; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis*; D004261:DNA Replication / Q000187:drug effects; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D005446:Fluocinolone Acetonide / Q000494:pharmacology*; D007700:Kinetics; D051379:Mice; D009955:Ornithine Decarboxylase / Q000378:metabolism*; D011700:Putrescine / Q000494:pharmacology; D012867:Skin / Q000187:drug effects / Q000378:metabolism*
D005446:Fluocinolone Acetonide; D004247:DNA; D002262:Carboxy-Lyases; D009955:Ornithine Decarboxylase; D011700:Putrescine
Cancer. 1961 Nov-Dec;14:1306-15
14008628
J Cell Biol. 1976 Mar;68(3):512-20
192729
Proc Natl Acad Sci U S A. 1977 Feb;74(2):657-61
191821
Chem Biol Interact. 1977 Jun;17(3):331-47
880700
J Natl Cancer Inst. 1976 Nov;57(5):1145-9
826651
Cancer Res. 1976 Nov;36(11 Pt 1):4062-8
975048
Chem Biol Interact. 1974 Jun;8(6):379-94
4846309
Nat New Biol. 1972 Feb 23;235(60):247-9
4502415
Cancer Res. 1974 Jul;34(7):1577-80
4365664
Cell. 1974 Aug;2(4):229-33
4369950
Biochem Biophys Res Commun. 1972 Jan 31;46(2):605-9
4333422
Cancer Res. 1976 Jul;36(7 PT 2):2644-53
1277170
Annu Rev Biochem. 1976;45:285-306
786151
Cancer Res. 1975 Jul;35(7):1662-70
48421
J Biochem. 1975 Apr;77(4):879-93
1150642
Cancer Res. 1975 Sep;35(9):2426-33
807325
Nature. 1975 Jun 26;255(5511):733-4
49027
Med Biol. 1975 Jun;53(3):121-47
169440
J Natl Cancer Inst. 1974 Oct;53(4):1093-7
4427390
J Invest Dermatol. 1974 Oct;63(4):343-9
4424714
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1975 Nov 25;84(3):325-44
128221
Exp Cell Res. 1974 May;86(1):95-105
4857507
CRC Crit Rev Toxicol. 1974 Jan;2(4):419-43
4822436
Cancer Res. 1973 Mar;33(3):542-6
4689903
Cancer Res. 1972 Mar;32(3):450-4
5061300
J Invest Dermatol. 1976 Jul;67(1):199-208
819592
Clin Exp Immunol. 1976 Apr;24(1):54-62
1084818
Proc Natl Acad Sci U S A. 1976 May;73(5):1626-30
1064034
Proc Natl Acad Sci U S A. 1976 Jun;73(6):1858-62
1064859
Nature. 1976 Jul 29;262(5567):402-4
958393
Proc Natl Acad Sci U S A. 1975 Oct;72(10):4042-5
1060087
Science. 1976 Feb 13;191(4227):571-2
1251193
Cancer Res. 1975 Oct;35(10):2884-90
1157054
Chem Biol Interact. 1975 Sep;11(3):225-33
1157191
Biochemistry. 1975 Oct 7;14(20):4403-9
1174509
Exp Cell Res. 1975 Jan;90(1):8-14
1168141